“Prescribing for the whole person”: A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand

Author:

Norman Kimberley,Cassim Shemana,Papa Valentina,Te-Karu Leanne,Clark Penny,Mullins Hilde,Chepulis Lynne

Abstract

Abstract Background Pharmacist prescribers have comprehensive pharmacotherapy knowledge that can be useful for management of complex health conditions such as type 2 diabetes, yet the number of pharmacist prescribers working in New Zealand primary care is low. Aim To explore the experiences of pharmacist prescribers in supporting type 2 diabetes management in New Zealand primary care. Methods Qualitative research design using semi-structured interviews with six pharmacist prescribers working in NZ primary care. Thematic analysis guided this study and themes were finalised with the wider research team. Results Three major themes were identified: team approach, health inequity and the role of a pharmacist prescriber. This study found that pharmacist prescribers may improve health equity by providing advanced pharmacotherapy knowledge within a wider primary care team to support complex patient needs and understanding the wider social determinants of health that impact effective diabetes management. Participants reportedly had more time to spend with patients (than GPs or nurses) and could also contribute to improving health outcomes by directly educating and empowering patients. Conclusion The views of pharmacist prescribers have seldom been explored and this study suggests that their role may be under-utilised in primary care. In particular, pharmacist prescribers can provide specialist prescribing (and often mobile) care, and may contribute to improving health outcomes and reducing inequity when used as part of a multi-disciplinary team.

Funder

Health Research Council of New Zealand

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Reference49 articles.

1. Medical Republic. How do pharmacists in other countries prescribe? 2022 [accessed 10.04.2023]. Available from: https://www.medicalrepublic.com.au/how-do-pharmacists-in-other-countries-prescribe/77517#:~:text=In%20the%20press%20and%20in,Zealand %2 C%20the%20UK%20and%20Canada.

2. Tonna A. An international overview of some pharmacist prescribing models. J Malta Coll Pharm Pract. 2008;14:20–6.

3. Tonna A, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK–a literature review of current practice and research. J Clin Pharm Ther. 2007;32[6]:545 – 56.

4. Emmerton L, Marriott J, Bessell T et al. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8[2]:217 – 25.

5. New Zealand Government. Medicines [Designated Pharmacist Prescribers] Regulations 2013 2013 [Available from: https://www.legislation.govt.nz/regulation/public/2013/0237/latest/DLM5229304.html. [accessed 10.04.2023].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3